The boundary worth testing
Clinic networks, central identity and outsourced support often have different owners. A temporary management route or shared support group can quietly become a permanent path to privileged access.
A patient portal can be well defended at the login screen while a laboratory integration accepts a record identifier without checking the requesting organisation. The valuable test follows those hand-offs, including the support processes that sit outside the main application.
What the scope can include
- External exposure and approved internal trust paths
- Active Directory/cloud identity and remote support access
- Segmentation between business, clinical and management tiers
- Backup administration and service-account permissions
The final proposal identifies the specific applications, accounts, environments and interfaces included. It also states which prerequisites your team or a supplier must provide.
What useful proof looks like
Validate named source/destination pairs and actual role permissions. Distinguish an open TCP path from an authenticated application capability, and distinguish administrative visibility from a destructive action.
Preserve UTC time, asset identifier, requesting principal, expected decision and observed response. State-changing tests need confirmation from the resulting object or a trusted audit record. Denied operations and effective controls remain part of the outcome.
Safety and assessment limits
Agent installation, password spraying, device interrogation and disruptive protocols need explicit inclusion. A limited network scope does not establish the security of every medical device.
Use synthetic patient identities and agreed data cohorts. Name a clinical escalation contact, set request limits and exclude treatment-affecting actions unless separately authorised. Stop immediately if testing encounters unexpected live clinical data or threatens a care workflow.
Close the loop
Connect each weakness to a named owner, immediate safeguard and durable correction. Define positive and negative retest cases so the change restores the intended boundary while preserving legitimate use. Open items retain their dependencies and deadlines.
Preview the sector sample report to see the evidence and treatment-plan format.
